Ledger.Open graph →
SEC Form D · filed December 10, 2020

Viracta Therapeutics, INC

Offering
$40.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cardiff, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Daniel Chevallard · Cardiff, CAExecSamuel Murphy · Cardiff, CADirectorIvor Royston · Cardiff, CAExec · DirectorRoger Pomerantz · Cardiff, CADirectorMichael Huang · Cardiff, CADirectorGur Roshwalb · Cardiff, CADirectorRichard Ghalie · Cardiff, CADirectorDavid Williams · New York, NYExecMark Little · WOBURN, MADirectorAmerigo Contini · Savannah, GADirectorSamuel Murphy · Cardiff, CADirectorPatrick Wilver · Savannah, GADirectorJean-Francois J. Legault · Cranberry Township, PADirectorRajesh Unni · WOBURN, MAExec · DirectorKen T. Denman · La Jolla, CAExec · DirectorLegendary Lodging VAB QOZ Manager, LLC · Fargo, NDDirectorBrandon R. Turner · Kihei, HIDirectorLansdowne General Partner I Limited · Grand Cayman, Cayman IslandsDirectorThomas R. Chamberlain · St Saviours, Y7ExecPeter Orser · Seattle, WADirectorKevin V. Dreyer · Rye, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗